Feasibility Study and Preliminary Results of Prognostic Value of Bone SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma to Abiraterone.

de Laroche, Romain; Bourhis, David; Robin, Philippe; Delcroix, Olivier; Querellou, Solène; Malhaire, Jean-Pierre; Schlurmann, Friederike; Bourbonne, Vincent; Salaün, Pierre-Yves; Schick, Ulrike; Abgral, Ronan

de Laroche, Romain; Bourhis, David; Robin, Philippe; Delcroix, Olivier; Querellou, Solène; Malhaire, Jean-Pierre; Schlurmann, Friederike; Bourbonne, Vincent; Salaün, Pierre-Yves; Schick, Ulrike; Abgral, Ronan.

Afiliação

de Laroche R; Nuclear Medicine Department, University Hospital Morvan, Brest, France.
Bourhis D; Nuclear Medicine Department, University Hospital Morvan, Brest, France.
Robin P; Université de Bretagne Occidentale, Brest, France.
Delcroix O; EA 3878 GETBO IFR 148, Brest, France.
Querellou S; Nuclear Medicine Department, University Hospital Morvan, Brest, France.
Malhaire JP; Université de Bretagne Occidentale, Brest, France.
Schlurmann F; EA 3878 GETBO IFR 148, Brest, France.
Bourbonne V; Nuclear Medicine Department, University Hospital Morvan, Brest, France.
Salaün PY; Université de Bretagne Occidentale, Brest, France.
Schick U; Nuclear Medicine Department, University Hospital Morvan, Brest, France.
Abgral R; Université de Bretagne Occidentale, Brest, France.

Front Med (Lausanne) ; 6: 342, 2019.

Article em En | MEDLINE | ID: mdl-32039220

Palavras-chave

SPECT-CT; bone scintigraphy; prognosis; prostate cancer; quantification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google